VACV evades p62 via early gene-mediated nuclear relocation. A) Incoming
Por um escritor misterioso
Descrição
Controlling Antigen Fate in Therapeutic Cancer Vaccines by Targeting Dendritic Cell Receptors
Vaccinia virus subverts xenophagy through phosphorylation and nuclear targeting of p62
Balancing STING in antimicrobial defense and autoinflammation - ScienceDirect
Vaccinia virus subverts xenophagy through phosphorylation and nuclear targeting of p62
Jason MERCER, Principal Investigator, Ph.D., University College London, London, UCL, MRC-Laboratory for Molecular Cell Biology
Membrane dynamics associated with viral infection - Armas‐Rillo - 2016 - Reviews in Medical Virology - Wiley Online Library
Anti-LAMP2 Antibody [H4B4] - BSA and Azide free (A86605)
Vaccinia virus subverts xenophagy through phosphorylation and nuclear targeting of p62
Controlling Antigen Fate in Therapeutic Cancer Vaccines by Targeting Dendritic Cell Receptors
Intracellular Virus Trafficking Reveals Physiological Characteristics of the Cytoskeleton
Frontiers Vaccinia Virus Activation and Antagonism of Cytosolic DNA Sensing
p62 bodies: Phase separation, NRF2 activation, and selective autophagic degradation - Komatsu - 2022 - IUBMB Life - Wiley Online Library
New Insights for Biosensing: Lessons from Microbial Defense Systems
de
por adulto (o preço varia de acordo com o tamanho do grupo)
